Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9038 |
High Similarity |
NPD5494 |
Approved |
0.882 |
High Similarity |
NPD3818 |
Discontinued |
0.8718 |
High Similarity |
NPD2801 |
Approved |
0.8693 |
High Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.8654 |
High Similarity |
NPD1934 |
Approved |
0.8625 |
High Similarity |
NPD1247 |
Approved |
0.8491 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8485 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8443 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8428 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8424 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8385 |
Intermediate Similarity |
NPD919 |
Approved |
0.8377 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8373 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8365 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8323 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8293 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.8278 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8269 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8255 |
Intermediate Similarity |
NPD1933 |
Approved |
0.8225 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8214 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.817 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8166 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8133 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8133 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8133 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8105 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8105 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8101 |
Intermediate Similarity |
NPD920 |
Approved |
0.8059 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8037 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8025 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8025 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8025 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7988 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7975 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7974 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7947 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7914 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7911 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7904 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7882 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7879 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.787 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7866 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7848 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7844 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7843 |
Intermediate Similarity |
NPD1607 |
Approved |
0.784 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.784 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7791 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7778 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7771 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7751 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7742 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7712 |
Intermediate Similarity |
NPD943 |
Approved |
0.764 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7636 |
Intermediate Similarity |
NPD37 |
Approved |
0.7616 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7607 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7605 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7605 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7605 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7595 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.758 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7568 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7545 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7531 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7515 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD3750 |
Approved |
0.75 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7472 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7459 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7451 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7444 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7442 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7439 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7436 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7436 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7427 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7423 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7423 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7423 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7421 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7421 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7399 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.738 |
Intermediate Similarity |
NPD5005 |
Approved |
0.738 |
Intermediate Similarity |
NPD5006 |
Approved |
0.7372 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7355 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7355 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7349 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7338 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7337 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7329 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7314 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7312 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7299 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7296 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7294 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7262 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7262 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7258 |
Intermediate Similarity |
NPD4420 |
Approved |
0.7247 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7239 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7222 |
Intermediate Similarity |
NPD2654 |
Approved |
0.72 |
Intermediate Similarity |
NPD17 |
Approved |
0.7193 |
Intermediate Similarity |
NPD5019 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7181 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7181 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7181 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7181 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7181 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7181 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7181 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7181 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7178 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7167 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7167 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7151 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7114 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7105 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7097 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7095 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7079 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7068 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7068 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7068 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7068 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7066 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7059 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7051 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7049 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7044 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7041 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7037 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7032 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7032 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7031 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7031 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7025 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7018 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7017 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6989 |
Remote Similarity |
NPD5710 |
Approved |
0.6989 |
Remote Similarity |
NPD5711 |
Approved |
0.6989 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6974 |
Remote Similarity |
NPD8151 |
Discontinued |
0.697 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6962 |
Remote Similarity |
NPD3027 |
Phase 3 |
0.6959 |
Remote Similarity |
NPD7584 |
Approved |
0.6959 |
Remote Similarity |
NPD1241 |
Discontinued |
0.6948 |
Remote Similarity |
NPD3972 |
Approved |
0.6943 |
Remote Similarity |
NPD3018 |
Phase 2 |
0.6936 |
Remote Similarity |
NPD5978 |
Approved |
0.6936 |
Remote Similarity |
NPD5977 |
Approved |
0.6928 |
Remote Similarity |
NPD6190 |
Approved |
0.6927 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6927 |
Remote Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6919 |
Remote Similarity |
NPD6280 |
Approved |
0.6919 |
Remote Similarity |
NPD6279 |
Approved |
0.6918 |
Remote Similarity |
NPD411 |
Approved |
0.6915 |
Remote Similarity |
NPD6534 |
Approved |
0.6915 |
Remote Similarity |
NPD6535 |
Approved |
0.691 |
Remote Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.6908 |
Remote Similarity |
NPD9268 |
Approved |
0.6905 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6904 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6904 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6901 |
Remote Similarity |
NPD7028 |
Phase 2 |
0.6893 |
Remote Similarity |
NPD6808 |
Phase 2 |
0.689 |
Remote Similarity |
NPD2353 |
Approved |
0.689 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.689 |
Remote Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.6883 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6882 |
Remote Similarity |
NPD4287 |
Approved |
0.6879 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6871 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6871 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6859 |
Remote Similarity |
NPD1876 |
Approved |
0.6853 |
Remote Similarity |
NPD7874 |
Approved |
0.6853 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6852 |
Remote Similarity |
NPD6651 |
Approved |
0.6845
|
Remote Similarity |
NPD4357 |
Discontinued |